Dermatology
Interleukin-targeting biologics
IL-inhibitor injections (e.g. dupilumab, secukinumab, ustekinumab) — Targeted antibody injections that block specific immune signals in severe eczema, psoriasis, asthma and arthritis.
Education and reference only. This is a plain-language class overview — it deliberately contains no doses. Always check the current Summary of Product Characteristics (SmPC), the BNF and your local formulary before prescribing or administering any medicine.
Quick answer
What is Interleukin-targeting biologics?
Interleukin-targeting biologics are antibody medicines, given by injection, that block specific immune signals (interleukins) driving conditions such as severe eczema, psoriasis, asthma and some forms of arthritis. They are used when standard treatments are not enough.
- How it works: Interleukins are messenger proteins the immune system uses to drive particular kinds of inflammation.
- In practice: In practice these biologics are targeted antibody treatments, given by injection, that block specific interleukin immune-signalling pathways and have transformed severe inflammatory disease — different agents for severe eczema and asthma (blocking the "type 2"/IL-4/IL-13 or IL-5 pathways), and psoriasis and psoriatic/axial arthritis (blocking IL-17 or IL-23).
What it is
Interleukin-targeting biologics are antibody medicines, given by injection, that block specific immune signals (interleukins) driving conditions such as severe eczema, psoriasis, asthma and some forms of arthritis. They are used when standard treatments are not enough.
How it works
Interleukins are messenger proteins the immune system uses to drive particular kinds of inflammation. Each biologic is engineered to neutralise one specific interleukin or its receptor, switching off that pathway precisely — so the disease it drives settles while the rest of the immune system is left more intact than with broad immunosuppression.
In practice
In practice these biologics are targeted antibody treatments, given by injection, that block specific interleukin immune-signalling pathways and have transformed severe inflammatory disease — different agents for severe eczema and asthma (blocking the "type 2"/IL-4/IL-13 or IL-5 pathways), and psoriasis and psoriatic/axial arthritis (blocking IL-17 or IL-23). They are specialist-initiated for moderate-to-severe disease that has not responded to standard treatment. Compared with broad immunosuppressants and older biologics, they are relatively targeted and generally well tolerated, often self-injected at home after training. The practical themes are: screening before starting (for infections including tuberculosis and hepatitis, depending on the agent), an infection focus during treatment (report signs of infection; live vaccines are avoided and ideally updated beforehand), injection-site reactions, and a few agent-specific points — for example eye-surface inflammation (conjunctivitis) with the eczema agent dupilumab, candida (thrush) infections with IL-17 blockers, and caution with IL-17 agents in inflammatory bowel disease, which they can worsen. Onset takes some weeks, and response is reviewed against agreed criteria to judge whether to continue.
Examples
Practical use
How to take it & use it well
- Before starting, you will usually be screened for infections such as tuberculosis and hepatitis, as these treatments calm the immune system and a hidden infection could flare up.
- Many of these are given as injections under the skin that you can learn to do at home, rotating the site each time and following the storage advice, which usually means keeping them in the fridge.
- Let an injection reach a comfortable temperature before using it, never use one that has been frozen or looks discoloured, and dispose of needles in a sharps bin.
- Be patient, as these treatments often take several weeks to build up their full effect, so keep going even if you do not notice an immediate change.
- Tell your team promptly about any signs of infection, such as fever, cough or feeling unwell, and avoid live vaccines unless your specialist agrees.
- Report side effects specific to your treatment, such as sore or red eyes, mouth or throat thrush, or any new or worsening tummy symptoms, so they can be managed early.
Common uses
- Moderate-to-severe eczema and psoriasis
- Severe (type 2/eosinophilic) asthma
- Psoriatic and axial arthritis (some agents)
Monitoring
- Disease response against agreed targets
- Infection signs and vaccination status
- Agent-specific effects (eyes, thrush, bowel symptoms)
Weighing it up
Advantages & disadvantages
Advantages
- They can dramatically improve conditions such as severe eczema, psoriasis and inflammatory arthritis when other treatments have failed.
- They target specific parts of the immune system, which can mean fewer broad effects than older immune-suppressing tablets.
- Many are self-injected at home, often only now and then, which fits around daily life.
- They can greatly improve quality of life, easing itch, pain, stiffness and skin symptoms.
- They are closely monitored, and there is growing experience with how to use them safely.
Disadvantages
- They raise the risk of infections, so screening beforehand and prompt reporting of symptoms are important.
- Live vaccines are generally avoided while taking them, as they may not be safe.
- Injection-site reactions, such as redness, swelling or soreness, are common.
- They can take several weeks to work, so they are not a quick fix.
- Each one has its own specific risks, such as eye inflammation, thrush or worsening of bowel inflammation.
Key safety principles
What to watch for
- Screen for infections (including TB and hepatitis, agent-dependent) before starting; report signs of infection during treatment and avoid live vaccines (update beforehand).
- Agent-specific effects: eye inflammation (conjunctivitis) with dupilumab; thrush with IL-17 blockers; IL-17 agents can worsen inflammatory bowel disease.
- Onset takes weeks — response is reviewed against agreed criteria; injection-site reactions are common.
Key interactions
What to avoid or check alongside
- Live vaccines are usually avoided, as a calmed immune system can make them unsafe, so plan any vaccines with your team.
- Combining them with other immune-suppressing medicines can add to the risk of infection and needs careful supervision.
- An untreated infection, including hidden tuberculosis or hepatitis, can flare under these treatments, which is why screening comes first.
- Tell your team about all your other medicines, as some immune treatments are not safely combined.
- Mention any planned surgery, as treatment may be paused around an operation to lower the infection risk.
Patient & carer advice
- It can be self-injected at home after training, and works over several weeks rather than instantly
- Report signs of infection, and tell vaccinators you are on a biologic (avoid live vaccines)
- Mention any new eye irritation, mouth/skin thrush or tummy/bowel symptoms depending on your medicine
Use with
Related clinical calculators
Dose and risk decisions for this class often depend on renal function, weight or bleeding/stroke risk. These tools help:
Answers
Interleukin-targeting biologics: frequently asked questions
Why am I screened for TB and hepatitis before starting?
These treatments calm part of your immune system, which can allow a hidden infection such as tuberculosis or hepatitis to wake up and spread. Screening beforehand finds and treats any such infection first, so you can start your biologic safely. It is a routine and important step.
How long do these injections take to work?
They usually build up their effect over several weeks rather than working straight away, so it is normal not to feel a difference at first. Keep using them as directed and give them time. Your team will review how well they are working and discuss next steps if needed.
Can I have vaccines while on a biologic?
Live vaccines are generally avoided because your immune system is calmed and they may not be safe. Non-live vaccines, including seasonal ones, are usually still recommended and encouraged. Always check with your specialist before any vaccine, and plan ahead where you can.
What side effects are specific to my biologic?
It depends on which one you take. Some can cause sore or red eyes, others can lead to mouth or throat thrush, and some can worsen bowel inflammation. Your team will tell you what to watch for with your particular treatment, so report any of these early.
What should I do if I think I have an infection?
Tell your team promptly if you get a fever, a persistent cough, burning when passing urine or feel generally unwell, as infections can take hold more easily on these treatments. Do not just wait it out, as an early check means any infection can be treated quickly and safely.
Authoritative sources
Always verify against the source
This overview is for orientation. For doses, interactions, contra-indications and the full monograph, use:
Related guides
Medicines in this class
Common interleukin-targeting biologics by active ingredient
Individual, dose-free guides to specific medicines in this class:
Used for
Conditions this class is used to treat
See how this class fits into the wider treatment picture for each condition:
Browse by body system
Part of the skin, hair & nails
See all the conditions, medicine classes and active-ingredient guides for this body system in one place:
Need a custom medicines or prescribing resource?
We build evidence-led clinical references, calculators and decision aids for teams.